Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure

Am Heart J. 2001 Dec;142(6):932-3. doi: 10.1067/mhj.2001.119611.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects*
  • Adrenergic beta-Antagonists / economics
  • Arrhythmias, Cardiac / chemically induced
  • Cardiotonic Agents / adverse effects*
  • Cardiotonic Agents / economics
  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Heart Failure / drug therapy*
  • Heart Transplantation
  • Hemodynamics / drug effects
  • Humans
  • Hypotension / chemically induced
  • Research Design
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Cardiotonic Agents